补肾方药对去卵巢雌鼠骨质疏松症防治作用的研究
摘要点击次数: 1967   全文下载次数: 1132   投稿时间:1997-12-24    
作者Author单位AddressE-Mail
陈训华 Chen Xunhua 中国中医研究院骨伤科研究所,北京100700 Institute of Orthopaedics and Traumatology China Academy of Traditional Chinese Medicine Beijing 100700  
危剑安 Wei Jianan 中国中医研究院广安门医院  
陈燕平 Chen Yanping 中国中医研究院骨伤科研究所,北京100700 Institute of Orthopaedics and Traumatology China Academy of Traditional Chinese Medicine Beijing 100700  
丁继华 中国中医研究院骨伤科研究所,北京100700 Institute of Orthopaedics and Traumatology China Academy of Traditional Chinese Medicine Beijing 100700  
周重光 中国中医研究院骨伤科研究所,北京100700 Institute of Orthopaedics and Traumatology China Academy of Traditional Chinese Medicine Beijing 100700  
张万强 中国中医研究院骨伤科研究所,北京100700 Institute of Orthopaedics and Traumatology China Academy of Traditional Chinese Medicine Beijing 100700  
高云 中国中医研究院骨伤科研究所,北京100700 Institute of Orthopaedics and Traumatology China Academy of Traditional Chinese Medicine Beijing 100700  
邢美荣 中国中医研究院骨伤科研究所,北京100700 Institute of Orthopaedics and Traumatology China Academy of Traditional Chinese Medicine Beijing 100700  
期刊信息:《中国骨伤》1998年,第11卷,第2期,第12-15页
DOI:doi:10.3969/j.issn.1003-0034.yyyy.nn.zzz
基金项目:家中医药管理局科研基金(No.922187)
中文摘要:

目的:为验证益肾填精方药“肾虚骨痛胶囊”防治骨质疏松症的疗效和探讨其治疗机理。

方法:本文以切除卵巢雌性大鼠复制绝经后骨质疏松症模型,观察该药对去卵巢大鼠抗失骨作用。实验分为模型组、肾虚骨痛胶囊大、小剂量组、骨疏康阳性对照组和正常对照组。术后1周开始给药,持续120天。

结果:肾虚骨痛胶囊大剂量组,与模型组比较,可以提高模鼠全身及股骨骨密度、股骨灰重、腰椎骨小梁体积、股骨无机元素 Ca、 P、 Mg、 Zn、 Cu、 Mn含量,血清E2含量用药后有增高之趋势,但与模型组比较无统计学差异。

结论:肾虚骨痛胶囊可通过体内多方位调节作用达到预防和抑制骨质疏松症的发生和发展,具有较好的应用前景。
【关键词】肾虚骨痛胶囊  去卵巢大鼠  骨质疏松症
 
Study on the Prevention and Treatment of Osteoporosis in Ovariectomized Rat with Kidney Tonifying Drugs
ABSTRACT  

Aim To test and verify the therapeutic effect of kidney tonifying and essence replenishing drugs. Shen Xu Gu Tong capsule (SXGTC), on prevention and treatment of osteoporosis and explore its therapeutic mechanism.

Methods Postmenopausal osteoporosis models of 48 female rats were modelled by ovariectomy and divided into 4 groups: model group, large-and small-dose groups of SXGTC, and Gu Shu Kang positive control group, and other 12 rats in intact control group. The administration of drugs were started one week after operation and continued for 120 days.

Results Comparing with model group, SXGTC in large dose can increase the bone density of the whole body skeleton and femur, the ash weight of femur, the volume of trabeculae in lumbar vertebra, and the contents of inorganic elements, Ca, P, Mg, Zn, Cu and Mn in femur. The content of serum E2 is inclinded to increase in SXGTC, but no statistical difference as compared with that in model group.

Conclusion SXGTC can prevent and inhibit the occurrence and development of osteoporosis through internal regulation in many ways. So there is a better prospect for clinical application.
KEY WORDS  Shen Xu Gu Tong  capsule  Ovariectomized  rat  Osteoporosis
 
引用本文,请按以下格式著录参考文献:
中文格式:陈训华,危剑安,陈燕平,丁继华,周重光,张万强,高云,邢美荣.补肾方药对去卵巢雌鼠骨质疏松症防治作用的研究[J].中国骨伤,1998,11(2):12~15
英文格式:Chen Xunhua,Wei Jianan,Chen Yanping.Study on the Prevention and Treatment of Osteoporosis in Ovariectomized Rat with Kidney Tonifying Drugs[J].zhongguo gu shang / China J Orthop Trauma ,1998,11(2):12~15
阅读全文  下载  查看/发表评论  下载PDF阅读器
关闭




版权所有:《中国骨伤》杂志社京ICP备12048066号-2  版权声明
地址:北京市东直门内南小街甲16号,100700
电话:010-64089487 传真:010-64089792 Email:zggszz@sina.com

京公网安备 11010102004237号